Posts Tagged: California Stem Cell Agency
Blood cells in a bone marrow smear, examined as part of stem cell research. (Photo: toeytoey, via Shutterstock)
California’s state stem cell agency is down to its last $67.3 million following a decision Thursday to back research to enhance bone healing in elderly patients who undergo spinal surgery. The $4 million award went to Ankasa Regenerative Therapeutics following little discussion among members of the governing board of the $3 billion California Institute for Regenerative Medicine.
Human fetal placenta under high magnification. (Photo: photowind, via Shutterstock
The California stem cell agency says the Trump administration’s moves against research involving fetal tissue have had no impact on the projects that it is financing, at least so far. The agency, formally known as the California Institute for Regenerative Medicine (CIRM), was responding to a question originally raised by a reader of the California Stem Cell Report.
A photo illustration of human DNA. (Photo: Shutterstock)
Plans to ask California voters in 2018 to approve a $5 billion bond issue to finance the California stem cell agency have been shelved, a director of the agency said Thursday. Jeff Sheehy, a San Francisco county supervisor, said that the key backer of the proposal had informed him that no bond measure would be offered to voters before 2020, presumably at the presidential general election.
A Liquid Nitrogen bank containing a suspension of stem cells. (Photo: Elena Pavlovich)
The California stem cell agency this week approved nearly $33 million for clinical stage research projects testing treatments for type 1 diabetes, arthritis of the knee, ALS and an immunodeficiency affliction.